Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits

Izabela Komarowska, Gad Heilweil, Philip J Rosenfeld, Ido Perlman, Anat Loewenstein

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To determine whether intravitreal injection of a commercially available ketorolac tromethamine preparation causes retinal toxicity in albino rabbits. METHODS:: Nine albino rabbits were injected intravitreally with ketorolac tromethamine (3 mg; 0.1 mL) in one eye and saline (0.1 mL) in the fellow eye. Six of the rabbits received a single injection of ketorolac, and the other three rabbits underwent biweekly injection for a total of four injections. Electroretinography testing was performed on both eyes at different time intervals during 4 weeks of follow-up in the single injection group, and during 12 weeks of follow-up in the multiple injection group. Visual evoked potentials were recorded from each rabbit using monocular and binocular stimulation at the end of the follow-up period. Animals were then killed, and the retinas were prepared for morphologic examination at the light microscope level and for immunostaining for glial fibrillary acidic protein, as a marker of retinal damage. RESULTS:: The electroretinography responses from the control and experimental eyes were similar throughout the follow-up period in all rabbits of both experimental groups. There were no differences in the flash visual evoked potential responses between experimental and control eyes in the single injection group, while in the repeated injection group, statistically significant differences were found. Light microscopy did not identify significant histologic differences between the retinas from control and experimental eyes after a single dose. However, after repeated dosing, two of three eyes showed histologic evidence of local toxicity. Immunocytochemical analysis showed no glial fibrillary acidic protein staining in Muller (glial) cells throughout the retina in the single injection group. Slight glial fibrillary acidic protein staining was detected in only one of the three retinas from rabbits in the repeated injection group. CONCLUSIONS:: Commercially available ketorolac tromethamine was found to be toxic to the retinas of albino rabbits following multiple intravitreal injections at a dose of 3 mg while no electrophysiologic toxicity was found. Therefore, the use of commercially available ketorolac containing alcohol, for intravitreal injection is not recommended.

Original languageEnglish
Pages (from-to)98-105
Number of pages8
JournalRetina
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Ketorolac
Rabbits
Injections
Ketorolac Tromethamine
Retina
Intravitreal Injections
Visual Evoked Potentials
Glial Fibrillary Acidic Protein
Electroretinography
Staining and Labeling
Ependymoglial Cells
Light
Poisons
Neuroglia
Microscopy
Alcohols

ASJC Scopus subject areas

  • Ophthalmology
  • Medicine(all)

Cite this

Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits. / Komarowska, Izabela; Heilweil, Gad; Rosenfeld, Philip J; Perlman, Ido; Loewenstein, Anat.

In: Retina, Vol. 29, No. 1, 01.01.2009, p. 98-105.

Research output: Contribution to journalArticle

Komarowska, Izabela ; Heilweil, Gad ; Rosenfeld, Philip J ; Perlman, Ido ; Loewenstein, Anat. / Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits. In: Retina. 2009 ; Vol. 29, No. 1. pp. 98-105.
@article{3f8081525ad2432ca7152d47f3390187,
title = "Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits",
abstract = "Purpose: To determine whether intravitreal injection of a commercially available ketorolac tromethamine preparation causes retinal toxicity in albino rabbits. METHODS:: Nine albino rabbits were injected intravitreally with ketorolac tromethamine (3 mg; 0.1 mL) in one eye and saline (0.1 mL) in the fellow eye. Six of the rabbits received a single injection of ketorolac, and the other three rabbits underwent biweekly injection for a total of four injections. Electroretinography testing was performed on both eyes at different time intervals during 4 weeks of follow-up in the single injection group, and during 12 weeks of follow-up in the multiple injection group. Visual evoked potentials were recorded from each rabbit using monocular and binocular stimulation at the end of the follow-up period. Animals were then killed, and the retinas were prepared for morphologic examination at the light microscope level and for immunostaining for glial fibrillary acidic protein, as a marker of retinal damage. RESULTS:: The electroretinography responses from the control and experimental eyes were similar throughout the follow-up period in all rabbits of both experimental groups. There were no differences in the flash visual evoked potential responses between experimental and control eyes in the single injection group, while in the repeated injection group, statistically significant differences were found. Light microscopy did not identify significant histologic differences between the retinas from control and experimental eyes after a single dose. However, after repeated dosing, two of three eyes showed histologic evidence of local toxicity. Immunocytochemical analysis showed no glial fibrillary acidic protein staining in Muller (glial) cells throughout the retina in the single injection group. Slight glial fibrillary acidic protein staining was detected in only one of the three retinas from rabbits in the repeated injection group. CONCLUSIONS:: Commercially available ketorolac tromethamine was found to be toxic to the retinas of albino rabbits following multiple intravitreal injections at a dose of 3 mg while no electrophysiologic toxicity was found. Therefore, the use of commercially available ketorolac containing alcohol, for intravitreal injection is not recommended.",
author = "Izabela Komarowska and Gad Heilweil and Rosenfeld, {Philip J} and Ido Perlman and Anat Loewenstein",
year = "2009",
month = "1",
day = "1",
doi = "10.1097/IAE.0b013e31817d8c09",
language = "English",
volume = "29",
pages = "98--105",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits

AU - Komarowska, Izabela

AU - Heilweil, Gad

AU - Rosenfeld, Philip J

AU - Perlman, Ido

AU - Loewenstein, Anat

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Purpose: To determine whether intravitreal injection of a commercially available ketorolac tromethamine preparation causes retinal toxicity in albino rabbits. METHODS:: Nine albino rabbits were injected intravitreally with ketorolac tromethamine (3 mg; 0.1 mL) in one eye and saline (0.1 mL) in the fellow eye. Six of the rabbits received a single injection of ketorolac, and the other three rabbits underwent biweekly injection for a total of four injections. Electroretinography testing was performed on both eyes at different time intervals during 4 weeks of follow-up in the single injection group, and during 12 weeks of follow-up in the multiple injection group. Visual evoked potentials were recorded from each rabbit using monocular and binocular stimulation at the end of the follow-up period. Animals were then killed, and the retinas were prepared for morphologic examination at the light microscope level and for immunostaining for glial fibrillary acidic protein, as a marker of retinal damage. RESULTS:: The electroretinography responses from the control and experimental eyes were similar throughout the follow-up period in all rabbits of both experimental groups. There were no differences in the flash visual evoked potential responses between experimental and control eyes in the single injection group, while in the repeated injection group, statistically significant differences were found. Light microscopy did not identify significant histologic differences between the retinas from control and experimental eyes after a single dose. However, after repeated dosing, two of three eyes showed histologic evidence of local toxicity. Immunocytochemical analysis showed no glial fibrillary acidic protein staining in Muller (glial) cells throughout the retina in the single injection group. Slight glial fibrillary acidic protein staining was detected in only one of the three retinas from rabbits in the repeated injection group. CONCLUSIONS:: Commercially available ketorolac tromethamine was found to be toxic to the retinas of albino rabbits following multiple intravitreal injections at a dose of 3 mg while no electrophysiologic toxicity was found. Therefore, the use of commercially available ketorolac containing alcohol, for intravitreal injection is not recommended.

AB - Purpose: To determine whether intravitreal injection of a commercially available ketorolac tromethamine preparation causes retinal toxicity in albino rabbits. METHODS:: Nine albino rabbits were injected intravitreally with ketorolac tromethamine (3 mg; 0.1 mL) in one eye and saline (0.1 mL) in the fellow eye. Six of the rabbits received a single injection of ketorolac, and the other three rabbits underwent biweekly injection for a total of four injections. Electroretinography testing was performed on both eyes at different time intervals during 4 weeks of follow-up in the single injection group, and during 12 weeks of follow-up in the multiple injection group. Visual evoked potentials were recorded from each rabbit using monocular and binocular stimulation at the end of the follow-up period. Animals were then killed, and the retinas were prepared for morphologic examination at the light microscope level and for immunostaining for glial fibrillary acidic protein, as a marker of retinal damage. RESULTS:: The electroretinography responses from the control and experimental eyes were similar throughout the follow-up period in all rabbits of both experimental groups. There were no differences in the flash visual evoked potential responses between experimental and control eyes in the single injection group, while in the repeated injection group, statistically significant differences were found. Light microscopy did not identify significant histologic differences between the retinas from control and experimental eyes after a single dose. However, after repeated dosing, two of three eyes showed histologic evidence of local toxicity. Immunocytochemical analysis showed no glial fibrillary acidic protein staining in Muller (glial) cells throughout the retina in the single injection group. Slight glial fibrillary acidic protein staining was detected in only one of the three retinas from rabbits in the repeated injection group. CONCLUSIONS:: Commercially available ketorolac tromethamine was found to be toxic to the retinas of albino rabbits following multiple intravitreal injections at a dose of 3 mg while no electrophysiologic toxicity was found. Therefore, the use of commercially available ketorolac containing alcohol, for intravitreal injection is not recommended.

UR - http://www.scopus.com/inward/record.url?scp=61549093399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549093399&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e31817d8c09

DO - 10.1097/IAE.0b013e31817d8c09

M3 - Article

C2 - 18626418

AN - SCOPUS:61549093399

VL - 29

SP - 98

EP - 105

JO - Retina

JF - Retina

SN - 0275-004X

IS - 1

ER -